Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy.
Saved in:
| Title: | Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy. |
|---|---|
| Authors: | Fatima S; Department of Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2031, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia., Ma Y; Department of Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; South Western Sydney Clinical School, UNSW, Sydney, NSW 2031, Australia.; Centre for Circulating Tumor Cell Diagnosis and Research, Ingham Institute for Applied Medical Research, Liverpool, NSW 2170, Australia., Safrachi A; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2031, Australia., Haider S; Department of Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia., Spring KJ; Department of Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia., Vafaee F; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2031, Australia.; UNSW Data Science Hub, University of New South Wales, Sydney, NSW 2031, Australia., Scott KF; Department of Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia., Roberts TL; Department of Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.; South Western Sydney Clinical School, UNSW, Sydney, NSW 2031, Australia., Becker TM; Department of Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.; South Western Sydney Clinical School, UNSW, Sydney, NSW 2031, Australia.; Centre for Circulating Tumor Cell Diagnosis and Research, Ingham Institute for Applied Medical Research, Liverpool, NSW 2170, Australia., de Souza P; Department of Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.; South Western Sydney Clinical School, UNSW, Sydney, NSW 2031, Australia. |
| Source: | Cancers [Cancers (Basel)] 2022 Mar 25; Vol. 14 (7). Date of Electronic Publication: 2022 Mar 25. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers14071669 |
